Effector Therapeutics Stock Price on August 23, 2021
| EFTR Stock | USD 1.78 0.08 4.71% |
If you're considering investing in Effector Stock, it is important to understand the factors that can impact its price. As of today, the current price of Effector Therapeutics stands at 1.78, as last reported on the 23rd of April, with the highest price reaching 1.87 and the lowest price hitting 1.63 during the day. Effector Therapeutics secures Sharpe Ratio (or Efficiency) of -0.086, which denotes the company had a -0.086% return per unit of risk over the last 3 months. Effector Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Effector Therapeutics' Standard Deviation of 12.24, variance of 149.84, and Mean Deviation of 6.8 to check the risk estimate we provide.
At this time, Effector Therapeutics' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 04/23/2024, Sale Purchase Of Stock is likely to grow to about 67.6 K, while Common Stock Shares Outstanding is likely to drop slightly above 1.5 M. . As of 04/23/2024, Price To Sales Ratio is likely to drop to 4.24. In addition to that, Price Earnings Ratio is likely to grow to -0.68. Effector Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Effector |
Sharpe Ratio = -0.086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EFTR |
Estimated Market Risk
| 12.6 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Effector Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Effector Therapeutics by adding Effector Therapeutics to a well-diversified portfolio.
Price Book 13.3845 | Enterprise Value Ebitda (0.30) | Price Sales 69.6486 | Shares Float 3.4 M | Wall Street Target Price 11 |
Effector Therapeutics Valuation on August 23, 2021
It is possible to determine the worth of Effector Therapeutics on a given historical date. On August 23, 2021 Effector was worth 95.25 at the beginning of the trading date compared to the closed value of 96.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Effector Therapeutics stock. Still, in general, we apply an absolute valuation method to find Effector Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Effector Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Effector Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/07/2022 | 95.25 | 99.75 | 90.46 | 96.00 | 370.00 |
| 95.75 | 99.75 | 90.50 | 96.00 | 463.00 |
| Backtest Effector Therapeutics | | | Effector Therapeutics History | | | Effector Therapeutics Valuation | Next |
Effector Therapeutics Trading Date Momentum on August 23, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Effector Therapeutics Fundamentals Correlations and Trends
By evaluating Effector Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Effector Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Effector financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Effector Therapeutics Stock history
Effector Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Effector is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Effector Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Effector Therapeutics stock prices may prove useful in developing a viable investing in Effector Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.2 M | 1.5 M | |
| Net Loss | -20.4 M | -19.4 M |
Effector Therapeutics Stock Technical Analysis
Effector Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Effector Therapeutics Period Price Range
Low | April 7, 2022
| High |
95.25 | 96.00 |
Effector Therapeutics April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Effector Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Effector Therapeutics shares will generate the highest return on investment. By undertsting and applying Effector Therapeutics stock market strength indicators, traders can identify Effector Therapeutics entry and exit signals to maximize returns
Effector Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Effector Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Effector Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Effector to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.70) | |||
| Total Risk Alpha | (2.85) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Effector Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Effector Stock, please use our How to Invest in Effector Therapeutics guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Effector Stock analysis
When running Effector Therapeutics' price analysis, check to measure Effector Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Effector Therapeutics is operating at the current time. Most of Effector Therapeutics' value examination focuses on studying past and present price action to predict the probability of Effector Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Effector Therapeutics' price. Additionally, you may evaluate how the addition of Effector Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Effector Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Effector Therapeutics. If investors know Effector will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Effector Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.37) | Revenue Per Share 0.349 | Quarterly Revenue Growth 1.17 | Return On Assets (0.85) | Return On Equity (9.47) |
The market value of Effector Therapeutics is measured differently than its book value, which is the value of Effector that is recorded on the company's balance sheet. Investors also form their own opinion of Effector Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Effector Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Effector Therapeutics' market value can be influenced by many factors that don't directly affect Effector Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Effector Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Effector Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Effector Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.